This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,795.28 firm fixed-price delivery order is for Chloraseptic Max 15-10 mg Loz 15s, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg lozenge products. The contract has a ceiling value of $1,076.82 and a period of performance through March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of CHLORASEPTIC MAX 15-10 MG LOZ 15S. The $13,759.31 firm fixed price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.09 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.62 firm fixed price delivery order is for the supply of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This contract award, valued at $2,241.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order for the supply of pharmaceutical products, specifically Chloraseptic Max 15-10 mg lozenges, to support military treatment programs and facilities. The contract has an ultimate completion date of April 11, 2024. This delivery...
This federal contract award, valued at $3,441.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product. The contract has a firm fixed price and has an ultimate completion date of November 7, 2024. This award is not associated with a set-aside designation, indicating open...
This federal contract award is a delivery order with a firm fixed price valued at $1,457.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566405605 - CHLORASEPTIC MAX 15-10 MG LOZ 15S, with a period of performance through November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,253.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award is for the delivery of Chloraseptic Max 15-10 mg lozenges under a Firm Fixed Price contract type. The contract has an ultimate completion date of September 5, 2024. This award does not utilize a set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for supplying these...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S medication. The contract has a ceiling value of $1,224.96 and a period of performance through October 15, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award, which is a Delivery Order...